Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.
Peter A Banks, Thomas L Bollen, Christos Dervenis...
https://pubmed.ncbi.nlm.nih.gov/23100216/Actively Recruiting
Led by Tokyo University · Updated on 2026-10-07
5000
Participants Needed
12
Research Sites
N/A
Total Duration
Researchers are conducting a multicenter prospective observational registry to study adults with local complications of acute pancreatitis or postoperative pancreatic fistula. The study aims to evaluate clinical characteristics and treatment outcomes in routine medical care settings. Because these complications are uncommon in individual centers, the study seeks to gather comprehensive data to better understand treatment selections, timing, and results. Participants receive routine clinical management chosen by their treating doctors, which may include conservative care, endoscopic or percutaneous drainage, necrosectomy, stent placement, or surgery when needed. The study does not assign any specific diagnostic or therapeutic interventions but observes treatments as they occur naturally in clinical practice. Throughout the study, data including patient characteristics, imaging findings, treatments, adverse events, recurrences, and outcomes will be collected. The primary goal is to assess clinical success within 180 days after enrollment. Secondary outcomes include technical success of initial interventions, adverse events, need for additional treatment, recurrence, mortality, and healthcare utilization. Participants may be followed for up to 180 days to monitor these outcomes.
CONDITIONS
Management and Outcomes of Local Complications of Acute Pancreatitis and Postoperative Pancreatic Fistula
Y
Yousuke Nakai, MD, PhD
T
Tomotaka Saito, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Tokyo University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 180 days after enrollment
Participants receive routine clinical care for their condition. Data on treatments, imaging, and outcomes are collected during this period without assigning specific interventions.
Regular visits as per clinical care
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Peter A Banks, Thomas L Bollen, Christos Dervenis...
https://pubmed.ncbi.nlm.nih.gov/23100216/Tokyo University
Lead Sponsor